Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...

"Botox and fillers are not even FDA-approved for most of the places we use them," she noted. "Some individuals might start ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication created ...